| Completed | A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" Rosacea | Phase 3 | 2019-04-15 |
| Completed | Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 1 Asthma | Phase 3 | 2019-03-25 |
| Completed | Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subj Asthma | Phase 3 | 2018-12-03 |
| Completed | Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension Cataract | Phase 3 | 2018-03-28 |
| Completed | Clinical Endpoint Study of Ivermectin 0.5% Lotion Head Lice | Phase 3 | 2017-10-07 |
| Completed | Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Asthma | Phase 3 | 2017-01-13 |
| Completed | An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Ker ACTINIC KERATOSIS | Phase 3 | 2016-08-19 |
| Completed | A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea | Phase 3 | 2016-07-19 |
| Completed | Clinical Endpoint Study of Ivermectin 1% Cream Moderate to Severe Papulopustular Rosacea | Phase 3 | 2016-06-01 |
| Completed | Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis Atrophic Vaginitis | Phase 3 | 2016-05-18 |
| Completed | Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea Diarrhea | Phase 3 | 2016-01-06 |
| Completed | Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment o Acne | Phase 3 | 2015-11-01 |
| Withdrawn | Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Ast Asthma | Phase 3 | 2015-09-01 |
| Completed | A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee Osteoarthritis | N/A | 2015-08-15 |
| Completed | Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne V Acne Vulgaris | Phase 3 | 2015-05-01 |
| Completed | Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophth Glaucoma | Phase 3 | 2015-04-01 |
| Completed | Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Kera Actinic Keratosis | Phase 3 | 2015-02-27 |
| Completed | A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Ker Actinic Keratosis | Phase 3 | 2015-02-01 |
| Completed | Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Atopic Dermatitis | Phase 3 | 2015-02-01 |
| Completed | Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate t Rosacea | Phase 3 | 2014-07-01 |
| Completed | A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulga Acne Vulgaris | Phase 3 | 2014-06-01 |
| Completed | Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain Ankle Sprain | Phase 3 | 2014-05-01 |
| Completed | A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Labor BACTERIAL VAGINOSIS, Signs and Symptoms to be Evaluated and Recorded Include, Vaginal Discharge Color, Odor, and Consistency | Phase 3 | 2014-01-01 |
| Completed | A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses Actinic Keratosis | Phase 3 | 2013-10-10 |
| Completed | A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Ros Rosacea | Phase 3 | 2013-07-01 |
| Completed | A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Actinic Keratosis | Phase 3 | 2013-03-01 |
| Completed | Clinical Equivalence Study of Mometasone Nasal Spray Seasonal Allergic Rhinitis | Phase 3 | 2013-02-01 |
| Withdrawn | Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects Healthy | Phase 1 | 2012-11-01 |
| Completed | Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment Actinic Keratoses | Phase 3 | 2008-05-01 |
| Completed | Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers Healthy | Phase 1 | 2007-04-01 |
| Completed | Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers Healthy | Phase 1 | 2007-02-01 |
| Completed | A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2006-10-01 |
| Completed | A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2006-10-01 |
| Completed | Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions Healthy | Phase 1 | 2006-08-01 |
| Completed | A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2006-08-01 |
| Completed | Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions Healthy | Phase 1 | 2006-08-01 |
| Completed | A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2006-08-01 |
| Completed | A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions Healthy | Phase 1 | 2006-07-01 |
| Completed | A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions Healthy | Phase 1 | 2006-06-01 |
| Completed | Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water Healthy | Phase 1 | 2006-05-01 |
| Completed | A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions Healthy | Phase 1 | 2006-04-01 |
| Completed | A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2006-03-01 |
| Completed | A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions Healthy | Phase 1 | 2006-01-01 |
| Completed | Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects Healthy | Phase 1 | 2005-11-01 |
| Completed | A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions Healthy | Phase 1 | 2005-11-01 |
| Completed | A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2005-10-01 |
| Completed | A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2005-10-01 |
| Completed | The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects Healthy | Phase 1 | 2005-10-01 |
| Completed | A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions Healthy | Phase 1 | 2005-09-01 |
| Completed | A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2005-09-01 |
| Completed | A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions Healthy | Phase 1 | 2005-07-01 |
| Completed | A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2005-05-01 |
| Completed | A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2005-05-01 |
| Completed | A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions Healthy | Phase 1 | 2005-04-01 |
| Completed | A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2005-04-01 |
| Completed | A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2005-04-01 |
| Completed | Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fe Healthy | Phase 1 | 2004-12-01 |
| Completed | A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions Healthy | Phase 1 | 2004-11-01 |
| Completed | A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2004-11-01 |
| Completed | Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fa Healthy | Phase 1 | 2004-11-01 |
| Completed | A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce Healthy | Phase 1 | 2004-10-01 |
| Completed | A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions Healthy | Phase 1 | 2004-10-01 |
| Completed | A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions Healthy | Phase 1 | 2004-09-01 |
| Completed | Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasti Healthy | Phase 1 | 2004-09-01 |
| Completed | Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesa Healthy | Phase 1 | 2004-09-01 |
| Completed | A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions Healthy | Phase 1 | 2004-09-01 |
| Completed | A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2004-08-01 |
| Completed | A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2004-08-01 |
| Completed | A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2004-08-01 |
| Completed | Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed C Healthy | Phase 1 | 2004-08-01 |
| Completed | A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions Healthy | Phase 1 | 2004-07-01 |
| Completed | A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2004-06-01 |
| Completed | Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults Healthy | Phase 4 | 2004-05-01 |
| Completed | A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2004-04-01 |
| Completed | A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions Healthy | Phase 1 | 2004-01-01 |
| Completed | Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Healthy | Phase 1 | 2003-12-01 |
| Completed | The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Healthy | Phase 1 | 2003-12-01 |
| Completed | A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions Healthy | Phase 1 | 2003-08-01 |
| Completed | A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2003-08-01 |
| Completed | A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2003-07-01 |
| Completed | A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2003-06-01 |
| Completed | A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System Healthy | Phase 1 | 2003-06-01 |
| Completed | A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed Conditions Healthy | Phase 1 | 2003-06-01 |
| Completed | A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2002-11-01 |
| Completed | A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2002-11-01 |
| Completed | A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions Healthy | Phase 1 | 2002-03-01 |
| Completed | A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2002-03-01 |
| Completed | A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2001-09-01 |
| Completed | A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting Conditions Healthy | Phase 1 | 2001-09-01 |
| Completed | A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Fasting Conditions Healthy | Phase 1 | 2001-02-01 |
| Completed | A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions Healthy | Phase 1 | 2001-02-01 |
| Completed | A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 1999-06-01 |
| Completed | A Limited Food Effect Study of Gabapentin 800 mg Tablets Healthy | Phase 1 | 1999-06-01 |
| Completed | A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions Healthy | Phase 1 | 1998-01-01 |
| Completed | A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions Healthy | Phase 1 | 1997-12-01 |